![Lin Xia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lin Xia
Hoofd Techniek/Wetenschap/O&O bij Shanghai Haihe Biopharma Co., Ltd.
Profiel
Lin Xia has worked as a Deputy Director of Preclinical Research and Development at Shanghai Haihe Biopharma Co., Ltd.
since 2017.
Actieve functies van Lin Xia
Bedrijven | Functie | Begin |
---|---|---|
Shanghai Haihe Biopharma Co., Ltd.
![]() Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Hoofd Techniek/Wetenschap/O&O | 01-01-2017 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Shanghai Haihe Biopharma Co., Ltd.
![]() Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |